SpectrumX confirms next step in clinical development of respiratory drug candidate SPX-001 after MHRA meeting
CEO Damien Hancox outlines next step after constructive scientific advice meeting with regulatory agency London – SpectrumX, a UK-based healthcare and pharmaceutical company, today announces that following a constructive scientific advice meeting with the Medicines and Healthcare products Regulatory Agency (MHRA) on Monday, 14th November, the Company is prepared to move forward with the next […]
